|
Match
|
Document |
Document Title |
|
|
US20090312417 |
PLATINUM(II) COMPLEXES, PREPARATION AND USE
The invention relates to a method for the preparation of platinum (II) complexes, in particular dicarboxylatoplatinum (II) complexes containing a neutral bidentate ligand, such as oxaliplatin. The...
|
|
|
US20090299085 |
PREPARATION OF PLATINUM(II) COMPLEXES
This invention relates to a method for the preparation of a platinum(II) complex containing a neutral bidentate ligand, such as oxaliplatin. The method includes the step of reacting a...
|
|
|
US20090291208 |
ATOMIC LAYER DEPOSITION USING METAL AMIDINATES
Metal films are deposited with uniform thickness and excellent step coverage. Copper metal films were deposited on heated substrates by the reaction of alternating doses of copper(I)...
|
|
|
US20090292134 |
NOVEL IRIDIUM-PLATINUM COMPLEX AND METHOD OF PRODUCING THE SAME
An iridium-platinum complex of the following formula:
wherein Cp* is a pentamethylcyclopentadienyl ligand or the like, X is a hydrogen atom, or a substituent group such as a bromine atom or an...
|
|
|
US20090285884 |
Platinum Complexes and Methods of Use
The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to...
|
|
|
US20090214626 |
Platinum Complexes For Targeted Drug Delivery
The subject invention concerns biotin-conjugated platinum complexes that exhibit direct and indirect (immunological) antitumor cell activity. The subject invention also concerns the biotin-platinum...
|
|
|
US20090199739 |
ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF
This invention relates to organometallic compounds having the formula (L 1 ) y M(L 2 ) z wherein M is a metal or metalloid, L 1 is the same or different and is (i) a substituted or unsubstituted...
|
|
|
US20090203928 |
ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF
This invention relates to organometallic compounds having the formula (L 1 ) y M(L 2 ) z wherein M is a metal or metalloid, L 1 is the same or different and is (i) a substituted or unsubstituted...
|
|
|
US20090179552 |
LIGHT EMITTING DEVICES AND COMPOSITIONS
A light emitting composition includes a light-emitting lumophore-functionalized nanoparticle, such as an organic-inorganic light-emitting lumophore-functionalized nanoparticle. A light emitting...
|
|
|
US20090131678 |
Novel reusable transition metal complex catalyst useful for the preparation of high pure quality 3,3'-diaminobenzidine and its analogues and a process thereof
The present invention provides a reusable transition metal complex catalyst useful for the preparation of high pure quality 3,3′-diaminobenzidine and its analogues. The present invention also...
|
|
|
US20090076139 |
DEUTERIUM-ENRICHED OXALPLATIN
The present application describes deuterium-enriched oxaliplatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090062573 |
Organic metal compound and process for preparing optically-active alcohols using the same
The present invention provides an asymmetric reduction catalyst effective in preparing optically-active alcohol compounds having various functional groups, and a process for preparing...
|
|
|
US20090030172 |
POLYMERIC SALEN COMPOUNDS AND METHODS THEREOF
The present disclosure provides a polymerizable compound of the formula (I)
where the R 1 , R 2 , R′ 1 , R′ 2 , X 1 to X 8 , Y 1 , Y 2 , M and L have any of values as defined in the...
|
|
|
US20090029221 |
FUNCTIONAL ANCHORS CONNECTING GRAPHENE-LIKE CARBON TO METAL
Functional linkers or anchors interconnecting graphene-like carbon, such as nanotubes or graphite sheets, with a conducting material such as a metal, are shown, together with related structures,...
|
|
|
US20080319061 |
Process for the Preparation of an Oxaliplatin Preparation
The present invention relates to an improved process for the preparation of oxaliplatin, the obtained oxaliplatin preparation and its use in cancer therapy.
|
|
|
US20080269425 |
Novel Catalyst
The present invention is directed to provide a catalyst for reduction, which is capable of reducing even mono-substituted alkynes to alkenes and does not require the coexistence (combined use) of a...
|
|
|
US20080269529 |
Chiral Compound Suitable as a Catalyst for Asymmetric Transfer Hydrogenation
The invention relates to an enantiomerically enriched chiral compound comprising a transition metal M, which comprises four, five or six coordinating groups of which at least one pair is linked...
|
|
|
US20080234525 |
Sulfonate Catalyst and Method of Producing Alcohol Compound Using the Same
A sulfonate catalyst represented by the formula below and a ketone compound are placed in a solvent, and the ketone compound is hydrogenated by mixing in the presence of hydrogen to produce an...
|
|
|
US20080207935 |
Process for the Preparation of an Anti-Tumor Platinum (II) - Complex
We disclose here processes for making Platinum complex of general formula (I) where in, the conformation of 1,2-diaminocyclohexane is cis, trans-l or trans-d isomer and R 1 and R 2 combinedly...
|
|
|
US20080194680 |
Platinum analogs with bis-nitrile-containing ligands
Disclosed herein are novel platinum-based analogs possessing two nitrile substituent groups (bis-nitrile) covalently-bonded to the platinum. Also disclosed herein are the reaction schemes for the...
|
|
|
US20080188678 |
Near-infrared-absorbing organic electrochromic materials
The invention provides generally a new type of organic electrochromic Near Infrared (NIR)-active materials capable of absorbing and attenuating the light in the NIR region around 1550 nm and...
|
|
|
US20080108841 |
CHELATING CARBENE LIGAND PRECURSORS AND THEIR USE IN THE SYNTHESIS OF METATHESIS CATALYSTS
Chelating ligand precursors for the preparation of olefin metathesis catalysts are disclosed. The resulting catalysts are air stable monomeric species capable of promoting various metathesis...
|
|
|
US20080096846 |
Arene Ruthenium (ll) Compounds And Their Use In Cancer Therapy
A ruthenium (II) compound of formula (I): or a solvate on prodrug thereof, wherein: R 1 , R 1 , R 3 , R 4 , R 5 and R 6 are independently selected from H, C 1-7 alkyl, C 5-20 aryl, C 3-20 ...
|
|
|
US20080081916 |
Method for Producing Optically Active Aziridine Compounds and Amine Compounds as Well as Complexes and their Intermadiates Used in this Method
This invention provides a method for producing an optically active aziridine compound or amine compound, which uses as a catalyst a Ru(salen)(CO) complex represented by the following formula (I) or...
|
|
|
US20080064895 |
Preparation of Platinum(II) Complexes
This invention relates to a method for the preparation of a platinum(II) complex containing a neutral bidentate ligand, such as oxaliplatin. The method includes the step of reacting a...
|
|
|
US20080045589 |
Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
The present invention relates to drug combinations and pharmaceutical compositions for treating cancer such as non-small cell lung carcinoma, said combination comprising (1) at least one...
|
|
|
US20080036373 |
Platinum complex and light-emitting device
A platinum complex represented by the general formula (1) below, useful as a phosphorescence emission material, a tetradentate ligand useful for synthesizing the platinum complex, and a...
|
|
|
US20080038371 |
Nanoparticle Formulations Of Platinum Compounds
Solid Lipid Nanoparticles of platinum compounds, particularly of antitumor platinum complexes are disclosed. The Nanoparticles of the invention are obtained by a process comprising: a) preparing a...
|